معرفی
Chun Jeih Ryu is a full-time Professor at the Department of Integrative Bioscience and Biotechnology, Sejong University, with a career spanning over 25 years in academia. He has held key roles including Principal Investigator at the Antibody Engineering Lab, KRIBB (2003-2006), and postdoctoral research at MIT's Center for Cancer Research (1998-2001).
- Ph.D., KAIST (1997)
- M.S., KAIST (1989)
- B.S., Yonsei University (1987)
His research interests focus on Stem Cell Biology, Cancer Stem Cells, Circulating Tumor Cells, and Antibody Engineering, with a strong emphasis on cancer cell surface markers and their therapeutic applications.
Recent research trends (2020-2025) highlight his work in:
- Engineering monoclonal antibodies for tumor suppression
- Investigating stem cell antigens in pluripotency regulation
- Elucidating signaling pathways in cancer progression
- Exploring molecular chaperones in stem cell states
Scientific awards include the Domestic Best Paper Award from KOFST (2017). He has authored 83 SCI(E) papers and holds 30 domestic/6 international patents, reflecting his prolific contributions to biomedical research.
As Principal Investigator at KRIBB's Antibody Engineering Lab (2003-2006), he pioneered antibody-based cancer therapies. His collaborations span global institutions, aligning with UN Sustainable Development Goals for health and innovation.
